rts logo

TXG Stock Forecast: All the More Reason to Consider 10x Genomics Inc (TXG) Now

10x Genomics Inc (NASDAQ: TXG) is -51.80% lower on its value in year-to-date trading and has touched a low of $24.60 and a high of $63.57 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The TXG stock was last observed hovering at around $25.99 in the last trading session, with the day’s gains setting it 0.98%.

Currently trading at $26.97, the stock is -3.09% and -20.58% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.97 million and changing 3.77% at the moment leaves the stock -37.50% off its SMA200. TXG registered -48.76% loss for a year compared to 6-month loss of -26.07%.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

The stock witnessed a -21.94% gain in the last 1 month and extending the period to 3 months gives it a -45.08%, and is -1.03% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.88% over the week and 6.00% over the month.

10x Genomics Inc (TXG) has around 1259 employees, a market worth around $3.23B and $625.45M in sales. Profit margin for the company is -42.26%. Distance from 52-week low is 9.63% and -57.57% from its 52-week high. The company has generated returns on investments over the last 12 months (-33.04%).

The EPS is expected to grow by 26.26% this year.

10x Genomics Inc (TXG) Top Institutional Holders

The shares outstanding are 105.04M, and float is at 98.53M with Short Float at 10.42%.

10x Genomics Inc (TXG) Insider Activity

The most recent transaction is an insider sale by Saxonov Serge,the company’sChief Executive Officer. SEC filings show that Saxonov Serge sold 4,660 shares of the company’s common stock on Mar 04 ’24 at a price of $44.00 per share for a total of $0.21 million. Following the sale, the insider now owns 0.84 million shares.

10x Genomics Inc disclosed in a document filed with the SEC on Feb 22 ’24 that Saxonov Serge (Chief Executive Officer) sold a total of 2,821 shares of the company’s common stock. The trade occurred on Feb 22 ’24 and was made at $46.34 per share for $0.13 million. Following the transaction, the insider now directly holds 0.85 million shares of the TXG stock.

Still, SEC filings show that on Feb 22 ’24, Hindson Benjamin J. disposed off 2,613 shares at an average price of $46.34 for $0.12 million. The insider now directly holds 283,059 shares of 10x Genomics Inc (TXG).

Related Posts